ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Kendle International Inc. (MM)

Kendle International Inc. (MM) (KNDL)

15.235
0.00
(0.00%)
Closed April 20 4:00PM
0.00
0.00
(0.00%)

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
15.235
Bid
0.00
Ask
0.00
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
15.235
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

KNDL Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TWGTop Wealth Group Holding Ltd
$ 3.73
(101.62%)
36.52M
CSLRComplete Solaria Inc
$ 0.465319
(75.59%)
16.64M
SHOTWSafety Shot Inc
$ 0.48
(60.00%)
6.71k
EGOXNext e GO NV
$ 0.0515
(43.06%)
333.3M
MNDRMobile health Network Solutions
$ 27.2386
(33.72%)
10.35M
YYAIConnexa Sports Technologies Inc
$ 0.8943
(-57.21%)
13.4M
SBFMSunshine Biopharma Inc
$ 1.77
(-46.69%)
11.9M
GTIGraphjet Technology
$ 6.43
(-33.09%)
95.33k
ISPCiSpecimen Inc
$ 0.2883
(-31.52%)
2.86M
BGLCBioNexus Gene Lab Corporation
$ 0.5998
(-29.32%)
735.88k
EGOXNext e GO NV
$ 0.0515
(43.06%)
333.3M
SQQQProShares UltraPro Short QQQ
$ 12.84
(6.38%)
219.91M
AGBAAGBA Group Holding Ltd
$ 1.255
(21.84%)
128.79M
TQQQProShares UltraPro QQQ
$ 49.48
(-6.20%)
125.4M
SINTSiNtx Technologies Inc
$ 0.0414
(3.50%)
109.94M

KNDL Discussion

View Posts
junkstocks junkstocks 13 years ago
Woo Hoo...First post in 2 years

INC Research to Acquire Kendle International for $15.25 per Share in Cash
👍️0
goldbarren58 goldbarren58 15 years ago
weeeeeeeee a third time

👍️0
goldbarren58 goldbarren58 15 years ago
wwwweeeeeee again
👍️0
elcheepo elcheepo 15 years ago
WEeeeeeeeeee all you want,,,, It is weee'ing season for KNDL!

WEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEE
👍️0
goldbarren58 goldbarren58 15 years ago
ok to weeeeee again?
👍️0
elcheepo elcheepo 15 years ago
I love big ole open spottages!!!....

(not really, but I thought it would be fun to say...lol)

14 about to tumble..

BTW... get in on SQNM... things are getting wiggy there.
👍️0
goldbarren58 goldbarren58 15 years ago
weeeeeeeee

fill that big ole open spottage
👍️0
elcheepo elcheepo 15 years ago
Going strong,,,,.
I think that we are in for some gappage coverage.
👍️0
goldbarren58 goldbarren58 15 years ago
in at 9.70

looking for 15 minimum but happy for now
👍️0
elcheepo elcheepo 15 years ago
May I ask why you are weeeeeeeeeeeeeeeeee'ing?
👍️0
goldbarren58 goldbarren58 15 years ago
EXCUSE ME BUT.....





weeeeeeeeeeeeeeeeeeeeeeeeeeeeee
👍️0
goldbarren58 goldbarren58 15 years ago
somebody get out and push
👍️0
Wildbilly Wildbilly 15 years ago
Looks like a small gappage so far this morning.
👍️0
z_deville z_deville 15 years ago
Breaks 11.50 and it will be in gappage area.
👍️0
crable crable 15 years ago
Hmm, not what I saw either!
👍️0
z_deville z_deville 15 years ago
lol
👍️0
goldbarren58 goldbarren58 15 years ago
Kendle beats by $0.17, beats on revs


MAYBE I read the wrong report


weeeeeeeeeeeeeee

see ya at 20
👍️0
crable crable 15 years ago
I grabbed some $12.50 calls at .15 yesterday. Very happy to see it up!!
👍️0
goldbarren58 goldbarren58 15 years ago
amazing premarket already


👍️0
crable crable 15 years ago
Tht was a HUGE misss!
👍️0
goldbarren58 goldbarren58 15 years ago
yikes
👍️0
z_deville z_deville 15 years ago
Kendle Announces First Quarter 2009 Results

* On Wednesday May 6, 2009, 8:16 pm EDT

*
Buzz up!
* Print

Related:

* Kendle International Inc.

CINCINNATI, May 6 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL - News), a leading, global full-service clinical research organization, today reported net income of $886,000 or $0.06 per share for the first quarter 2009 compared with net income of $4.1 million or $0.27 per diluted share for the first quarter 2008. On a pro forma basis, net income for the first quarter of 2009 was $0.47 per diluted share compared with $0.38 per diluted share in the first quarter of 2008.
Related Quotes
Symbol Price Change
KNDL 9.61 +0.04
Chart for Kendle International Inc.
{"s" : "kndl","k" : "c10,l10,p20,t10","o" : "","j" : ""}

(Logo: http://www.newscom.com/cgi-bin/prnh/20080923/CLTU095LOGO)

First Quarter 2009 Results

Net service revenues for the quarter ended March 31, 2009, totaled $108.1 million, a decrease of 5 percent compared with the same period in 2008. Excluding the impact of foreign exchange rates, revenues for the quarter increased 8 percent compared with the same period in 2008.

Income from operations for the three months ended March 31, 2009, was $8.1 million or 7.5 percent of net service revenues versus $14.0 million or 12.2 percent of net service revenues for first quarter 2008. The reduction in operating income is largely attributable to the decline of net service revenues for the quarter. Excluding the impact of foreign exchange rates, income from operations for the period ended March 31, 2009 would have been $11.4 million or 9.3 percent of net service revenues on a constant currency basis.

Effective Jan. 1, 2009, Kendle adopted APB 14-1 which increased interest expense for additional non-cash interest amounting to $1.7 million and $1.5 million for the periods ended March 31, 2009 and 2008 respectively.

The effective tax rate for the first quarter of 2009 was 88.4 percent compared with the as adjusted effective tax rate for 2008 of 42.9 percent. Included in the first quarter 2009 tax expense and effective tax rate is $4.4 million or $0.30 per diluted share of tax expense relating to the unwinding of a Pound Sterling foreign currency hedge.

Pro forma earnings per share, excluding the impact of APB 14-1 and the additional expense related to the foreign currency hedge, is $0.47 per diluted share compared with $0.38 per diluted share for the same period last year.

Cash flow from operations for first quarter 2009 was $8.3 million. Cash, cash equivalents and marketable securities at March 31, 2009, totaled $56.0 million. Days sales outstanding in accounts receivables were 38 days compared with 45 days in the first quarter of 2008. Capital expenditures for the quarter ended March 31, 2009, totaled $5.4 million.

Total new business authorizations at March 31, 2009 were $930 million compared with $1.0 billion at Dec. 31, 2008 and $917 million at March 31, 2008. New business awards in first quarter 2009 were $72 million compared with $180 million for the same period last year. Contract cancellations in the first quarter were $52 million.

Margin Improvement and Cost Reduction Initiatives

In the second quarter 2009, the Company implemented a series of initiatives to reduce its variable costs. These initiatives include strict controls over all discretionary spending, a hiring and wage freeze, and workforce and capacity optimization initiatives to better balance our staffing levels with customer demand. The Company expects to take a one-time charge in the second quarter of 2009 for severance-related and other expenses in the range of $3.5 million to $4.5 million. The Company anticipates these initiatives will generate savings of between $17.5 million and $22.5 million in the second half of 2009.

Organizational Structure

The Company announced that it plans to adjust its organizational and leadership structure in order to deliver operational excellence, efficiency, and cost savings for customers. In addition to enhancing business development efforts, the Company plans to consolidate positions in a number of operational groups and by year end, operations will be more functional in structure, driving costs from middle management and building synergies across various groups such as Phase II-III Clinical Development and Late Phase, and Clinical Monitoring and Clinical Data Management.

"We are taking aggressive steps to enhance our business development efforts, realign our leadership and organizational structure and implement a series of margin improvement and cost reduction initiatives to move our business to the next level," said Chairman and CEO Candace Kendle, PharmD.

Dr. Kendle continued, "Kendle is well-positioned with the leadership, financial strength and industry-leading service offerings necessary to weather the current challenges and emerge even stronger. Over the long term we believe the fundamentals of the CRO industry will remain quite positive."

First Quarter 2009 Conference Call and Webcast Details

Kendle will host its First Quarter 2009 conference call on May 7, 2009, at 8:30 a.m. Eastern Time. The call will be broadcast live over the Internet and can be accessed at www.kendle.com. A replay of the Webcast will be available at www.kendle.com shortly after the call for on-demand replay through 5 p.m. Eastern Time on June 5, 2009.
👍️0
goldbarren58 goldbarren58 15 years ago
basties are toying with us
👍️0
z_deville z_deville 15 years ago
not yet but keeping a close eye.
👍️0
crable crable 15 years ago
Seen ER yet? I grabbed those .15 calls so I am hoping it at least meets estimates
👍️0
z_deville z_deville 15 years ago
I'll be there
👍️0
goldbarren58 goldbarren58 15 years ago
np see ya at 20
👍️0
z_deville z_deville 15 years ago
In too and I agree. Looks to be an overreaction selloff.
Thanks for stopping by. I decided to create the board being there wasn't one.
👍️0
goldbarren58 goldbarren58 15 years ago
I am in and ready to rip
👍️0
z_deville z_deville 15 years ago
Earnings AH today.
👍️0

Your Recent History

Delayed Upgrade Clock